MARATTO

article · Naunyn-Schmiedeberg s Archives of Pharmacology

Repurposing doxycycline as an adjunct to sitagliptin in type 2 diabetes mellitus: a randomized controlled study on glycemic, inflammatory, and cardiometabolic outcomes

2026Kafr el-Sheikh University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Diabetes Treatment and Management
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1007/s00210-026-05510-7

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.